Investigation of cofactor (CoF) activity applied in combination with 5-fluorouracil (5-FU) against two human colon cancer cell lines

被引：0
|
作者：
Radulovic, Sinisa S. [1 ]
Bjelogrlic, Snezana K. [1 ]
Srdic, Tanja V. [1 ]
机构：
[1] Inst Oncol & Radiol Serbia, Belgrade, Serbia
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [31] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC)
    Cavanna, Luigi
    Artioli, Fabrizio
    Codignola, Claudio
    Lazzaro, Antonio
    Rizzi, Anna
    Gamboni, Alessandro
    Rota, Luigina
    Rodino, Carmelina
    Boni, Fabrizio
    Iop, Aldo
    Zaniboni, Alberto
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 371 - 375
  • [32] METABOLIC ENHANCEMENT OF 5-FLUOROURACIL (5-FU) INCORPORATION INTO HUMAN-TUMOR CELL RNA
    KUFE, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 265 - 265
  • [33] Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU
    Pronzato, P
    Vaira, F
    Viganni, A
    Losardo, P
    Bertelli, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 760 - 760
  • [34] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [35] The role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil (5-FU) in colorectal cancer cell lines
    Arnold, CN
    Goel, A
    Boland, CR
    GASTROENTEROLOGY, 2002, 122 (04) : A121 - A121
  • [36] In vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer
    Inoue, Y
    Tanaka, K
    Hiro, J
    Yoshiyama, S
    Toiyama, Y
    Eguchi, T
    Miki, C
    Kusunoki, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (02) : 479 - 486
  • [37] Antitumor effects of 5-fluorouracil on human colon cancer cell lines: Antagonism by levamisole
    Wiebke, EA
    Grieshop, NA
    Loehrer, PJ
    Eckert, GJ
    Sidner, RA
    JOURNAL OF SURGICAL RESEARCH, 2003, 111 (01) : 63 - 69
  • [38] Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
    Taïeb, J
    Artru, P
    Baujat, B
    Mabro, M
    Carola, E
    Maindrault, F
    Tournigand, C
    Krulik, M
    Louvet, C
    de Gramont, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 661 - 666
  • [39] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
  • [40] Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer
    Chester, JD
    Dent, JT
    Wilson, G
    Ride, E
    Seymour, MT
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 235 - 237
12345